Everett Magann
Concepts (805)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pregnancy | 360 | 2025 | 2680 | 12.620 |
Why?
| Amniotic Fluid | 71 | 2023 | 108 | 12.170 |
Why?
| Pregnancy Complications | 58 | 2025 | 400 | 10.820 |
Why?
| Ultrasonography, Prenatal | 69 | 2023 | 190 | 9.870 |
Why?
| Pregnancy Outcome | 96 | 2024 | 250 | 9.700 |
Why?
| Oligohydramnios | 44 | 2023 | 60 | 6.060 |
Why?
| Premature Birth | 28 | 2023 | 153 | 5.800 |
Why?
| Cesarean Section | 68 | 2024 | 184 | 5.790 |
Why?
| Obstetrics | 22 | 2022 | 89 | 5.310 |
Why?
| Female | 384 | 2025 | 28171 | 5.000 |
Why?
| Delivery, Obstetric | 45 | 2024 | 122 | 4.880 |
Why?
| Gestational Age | 80 | 2024 | 417 | 4.330 |
Why?
| Humans | 391 | 2025 | 52483 | 3.590 |
Why?
| Prenatal Care | 14 | 2023 | 110 | 3.510 |
Why?
| Polyhydramnios | 20 | 2023 | 31 | 3.400 |
Why?
| Pre-Eclampsia | 26 | 2024 | 59 | 3.380 |
Why?
| Infant, Newborn | 114 | 2024 | 2867 | 3.310 |
Why?
| Telemedicine | 13 | 2023 | 494 | 3.240 |
Why?
| Adult | 224 | 2024 | 14161 | 3.220 |
Why?
| Postpartum Hemorrhage | 12 | 2018 | 39 | 3.110 |
Why?
| Labor Stage, Third | 9 | 2018 | 19 | 3.090 |
Why?
| Placenta | 12 | 2022 | 153 | 2.960 |
Why?
| Obstetric Labor Complications | 20 | 2020 | 33 | 2.920 |
Why?
| Fetal Membranes, Premature Rupture | 7 | 2023 | 23 | 2.660 |
Why?
| Uterine Rupture | 6 | 2023 | 11 | 2.540 |
Why?
| Pregnancy, High-Risk | 16 | 2021 | 54 | 2.500 |
Why?
| Fetal Diseases | 8 | 2022 | 61 | 2.450 |
Why?
| Hypertension, Pregnancy-Induced | 6 | 2024 | 19 | 2.340 |
Why?
| Military Personnel | 15 | 2013 | 177 | 2.330 |
Why?
| HELLP Syndrome | 27 | 2007 | 27 | 2.280 |
Why?
| Twins | 19 | 2014 | 33 | 2.100 |
Why?
| Prospective Studies | 80 | 2024 | 2481 | 2.030 |
Why?
| Labor, Induced | 20 | 2020 | 25 | 1.960 |
Why?
| Birth Weight | 29 | 2020 | 125 | 1.940 |
Why?
| Pregnancy Complications, Cardiovascular | 13 | 2024 | 37 | 1.910 |
Why?
| Risk Factors | 58 | 2025 | 3889 | 1.890 |
Why?
| Diabetes, Gestational | 6 | 2024 | 53 | 1.770 |
Why?
| Hypertension | 18 | 2024 | 565 | 1.740 |
Why?
| Pregnancy Complications, Neoplastic | 3 | 2024 | 24 | 1.640 |
Why?
| Parturition | 8 | 2023 | 50 | 1.620 |
Why?
| Labor, Obstetric | 16 | 2023 | 43 | 1.590 |
Why?
| Fetal Growth Retardation | 15 | 2016 | 40 | 1.570 |
Why?
| Gynecology | 8 | 2022 | 52 | 1.520 |
Why?
| Obstetric Labor, Premature | 18 | 2016 | 35 | 1.500 |
Why?
| Infant, Small for Gestational Age | 13 | 2024 | 35 | 1.500 |
Why?
| Postpartum Period | 16 | 2024 | 109 | 1.360 |
Why?
| Retrospective Studies | 68 | 2023 | 6607 | 1.350 |
Why?
| Surgical Wound Dehiscence | 4 | 2021 | 20 | 1.310 |
Why?
| Pregnancy, Abdominal | 3 | 2015 | 10 | 1.310 |
Why?
| Vaginal Birth after Cesarean | 6 | 2023 | 9 | 1.280 |
Why?
| Pregnancy Trimester, Third | 18 | 2022 | 57 | 1.270 |
Why?
| Uterine Diseases | 4 | 2020 | 10 | 1.260 |
Why?
| Hemorrhage | 7 | 2023 | 209 | 1.240 |
Why?
| Dye Dilution Technique | 9 | 2014 | 16 | 1.240 |
Why?
| Ultrasonography | 20 | 2023 | 430 | 1.220 |
Why?
| Congenital Abnormalities | 7 | 2021 | 118 | 1.220 |
Why?
| Rural Health Services | 4 | 2016 | 170 | 1.210 |
Why?
| Young Adult | 40 | 2024 | 4329 | 1.180 |
Why?
| Domestic Violence | 4 | 2012 | 23 | 1.160 |
Why?
| Obesity, Morbid | 4 | 2018 | 87 | 1.140 |
Why?
| Peripartum Period | 4 | 2022 | 15 | 1.140 |
Why?
| Abortion, Spontaneous | 2 | 2022 | 21 | 1.120 |
Why?
| Fetal Distress | 21 | 2020 | 22 | 1.120 |
Why?
| Ultrasonography, Doppler, Color | 5 | 2019 | 33 | 1.110 |
Why?
| Pregnancy Complications, Infectious | 6 | 2021 | 81 | 1.110 |
Why?
| Fetal Weight | 8 | 2014 | 12 | 1.100 |
Why?
| Fetal Death | 7 | 2022 | 24 | 1.100 |
Why?
| Fetus | 7 | 2020 | 194 | 1.100 |
Why?
| Cervical Ripening | 8 | 2016 | 9 | 1.060 |
Why?
| Uterus | 10 | 2023 | 88 | 1.030 |
Why?
| Pregnancy Complications, Hematologic | 6 | 2021 | 16 | 1.010 |
Why?
| Parity | 21 | 2020 | 52 | 1.000 |
Why?
| Adolescent | 57 | 2025 | 6739 | 0.990 |
Why?
| Dystocia | 9 | 2014 | 10 | 0.960 |
Why?
| Restless Legs Syndrome | 1 | 2025 | 11 | 0.950 |
Why?
| Maternal Mortality | 6 | 2020 | 30 | 0.950 |
Why?
| Fetal Macrosomia | 12 | 2015 | 20 | 0.950 |
Why?
| Morbidity | 8 | 2023 | 145 | 0.930 |
Why?
| Body Mass Index | 13 | 2020 | 689 | 0.930 |
Why?
| Referral and Consultation | 5 | 2015 | 292 | 0.920 |
Why?
| Surgical Wound Infection | 7 | 2017 | 118 | 0.920 |
Why?
| Time Factors | 35 | 2024 | 2968 | 0.900 |
Why?
| Uterine Prolapse | 1 | 2023 | 3 | 0.860 |
Why?
| Umbilical Cord | 2 | 2020 | 36 | 0.850 |
Why?
| Mass Screening | 5 | 2012 | 357 | 0.850 |
Why?
| Cervix Uteri | 9 | 2014 | 49 | 0.850 |
Why?
| Pelvic Girdle Pain | 1 | 2023 | 2 | 0.840 |
Why?
| Pregnancy, Multiple | 6 | 2007 | 23 | 0.830 |
Why?
| Antihypertensive Agents | 4 | 2024 | 132 | 0.830 |
Why?
| Esophageal Neoplasms | 1 | 2024 | 111 | 0.820 |
Why?
| Adrenal Gland Diseases | 1 | 2023 | 8 | 0.810 |
Why?
| Adrenal Insufficiency | 1 | 2023 | 18 | 0.810 |
Why?
| Health Services Accessibility | 4 | 2021 | 436 | 0.800 |
Why?
| Adenomyosis | 1 | 2022 | 1 | 0.800 |
Why?
| Prenatal Diagnosis | 7 | 2022 | 103 | 0.790 |
Why?
| Adrenal Cortex Hormones | 4 | 2017 | 116 | 0.790 |
Why?
| Arkansas | 15 | 2025 | 2028 | 0.780 |
Why?
| Maternal Death | 1 | 2022 | 7 | 0.780 |
Why?
| Blood Loss, Surgical | 7 | 2012 | 71 | 0.770 |
Why?
| Rural Population | 4 | 2022 | 577 | 0.770 |
Why?
| Cystitis | 1 | 2022 | 17 | 0.760 |
Why?
| Respiratory Distress Syndrome, Newborn | 8 | 2017 | 52 | 0.760 |
Why?
| Hyperparathyroidism | 1 | 2022 | 31 | 0.750 |
Why?
| Health Status Disparities | 2 | 2022 | 215 | 0.740 |
Why?
| Obesity | 8 | 2020 | 1162 | 0.740 |
Why?
| Postmenopause | 1 | 2022 | 82 | 0.740 |
Why?
| Privacy | 1 | 2021 | 18 | 0.730 |
Why?
| Stomach Neoplasms | 1 | 2024 | 194 | 0.720 |
Why?
| Communication Barriers | 1 | 2021 | 31 | 0.710 |
Why?
| Spinal Cord Injuries | 1 | 2021 | 55 | 0.690 |
Why?
| Practice Guidelines as Topic | 10 | 2020 | 488 | 0.680 |
Why?
| Torsion Abnormality | 1 | 2020 | 4 | 0.680 |
Why?
| Predictive Value of Tests | 29 | 2019 | 944 | 0.680 |
Why?
| Education, Medical | 1 | 2022 | 111 | 0.670 |
Why?
| Pregnancy, Twin | 3 | 2014 | 8 | 0.670 |
Why?
| Medically Underserved Area | 1 | 2020 | 46 | 0.660 |
Why?
| Carcinoma, Signet Ring Cell | 1 | 2019 | 14 | 0.650 |
Why?
| Placenta Diseases | 1 | 2019 | 15 | 0.650 |
Why?
| Dexamethasone | 9 | 2016 | 438 | 0.650 |
Why?
| Fetal Monitoring | 10 | 2013 | 36 | 0.640 |
Why?
| Health Personnel | 2 | 2020 | 256 | 0.640 |
Why?
| Prevalence | 11 | 2025 | 1006 | 0.630 |
Why?
| Disease Management | 1 | 2021 | 188 | 0.630 |
Why?
| Heart Rate, Fetal | 15 | 2016 | 61 | 0.630 |
Why?
| Urinary Bladder Calculi | 1 | 2018 | 4 | 0.620 |
Why?
| Simplexvirus | 1 | 2019 | 15 | 0.620 |
Why?
| Women's Health Services | 1 | 2019 | 15 | 0.620 |
Why?
| Herpes Simplex | 1 | 2019 | 23 | 0.610 |
Why?
| Lymphatic Metastasis | 1 | 2019 | 220 | 0.610 |
Why?
| Military Medicine | 1 | 2019 | 24 | 0.610 |
Why?
| Pregnancy Trimester, Second | 13 | 2020 | 27 | 0.610 |
Why?
| Fetal Mortality | 3 | 2015 | 7 | 0.610 |
Why?
| Uterine Inversion | 1 | 2018 | 1 | 0.600 |
Why?
| Incidence | 17 | 2025 | 1062 | 0.600 |
Why?
| Stillbirth | 4 | 2022 | 29 | 0.600 |
Why?
| Mississippi | 12 | 2015 | 90 | 0.590 |
Why?
| Sensitivity and Specificity | 23 | 2017 | 891 | 0.590 |
Why?
| Fetal Blood | 11 | 2010 | 80 | 0.590 |
Why?
| Women, Working | 2 | 2012 | 4 | 0.580 |
Why?
| Magnesium Sulfate | 8 | 2016 | 12 | 0.580 |
Why?
| Intensive Care Units, Neonatal | 3 | 2015 | 135 | 0.580 |
Why?
| Patient Satisfaction | 3 | 2023 | 284 | 0.570 |
Why?
| Diverticulum | 1 | 2017 | 21 | 0.560 |
Why?
| Internship and Residency | 2 | 2022 | 448 | 0.560 |
Why?
| Blood Pressure | 11 | 2024 | 537 | 0.560 |
Why?
| Infant, Premature | 5 | 2015 | 333 | 0.540 |
Why?
| Apgar Score | 20 | 2018 | 35 | 0.540 |
Why?
| Stroke | 1 | 2022 | 512 | 0.530 |
Why?
| Imaging, Three-Dimensional | 2 | 2019 | 154 | 0.530 |
Why?
| Uterine Retroversion | 1 | 2016 | 2 | 0.530 |
Why?
| Infant Mortality | 10 | 2013 | 61 | 0.530 |
Why?
| Brachial Plexus Neuropathies | 2 | 2014 | 11 | 0.520 |
Why?
| Pregnant Women | 4 | 2023 | 70 | 0.510 |
Why?
| Fish Products | 1 | 2016 | 2 | 0.510 |
Why?
| Pregnancy Complications, Parasitic | 1 | 2016 | 3 | 0.510 |
Why?
| Gastroschisis | 1 | 2016 | 39 | 0.510 |
Why?
| Reproducibility of Results | 14 | 2021 | 1229 | 0.510 |
Why?
| Foodborne Diseases | 1 | 2016 | 14 | 0.510 |
Why?
| Genetic Counseling | 1 | 2016 | 43 | 0.500 |
Why?
| Respiration Disorders | 1 | 2015 | 23 | 0.490 |
Why?
| Hydroxyprogesterones | 4 | 2021 | 6 | 0.490 |
Why?
| Adenocarcinoma | 1 | 2019 | 405 | 0.490 |
Why?
| Genetic Testing | 1 | 2016 | 129 | 0.490 |
Why?
| Death Certificates | 1 | 2015 | 18 | 0.480 |
Why?
| Birth Certificates | 1 | 2015 | 26 | 0.480 |
Why?
| Odds Ratio | 9 | 2016 | 558 | 0.480 |
Why?
| Tertiary Care Centers | 2 | 2015 | 85 | 0.480 |
Why?
| Tocolysis | 5 | 2015 | 5 | 0.480 |
Why?
| Nifedipine | 4 | 2024 | 25 | 0.480 |
Why?
| Uterine Hemorrhage | 4 | 2021 | 11 | 0.470 |
Why?
| Regression Analysis | 13 | 2018 | 401 | 0.470 |
Why?
| Monitoring, Ambulatory | 1 | 2015 | 8 | 0.470 |
Why?
| Catheterization | 3 | 2011 | 96 | 0.470 |
Why?
| Magnetic Resonance Imaging | 4 | 2022 | 1546 | 0.460 |
Why?
| Exercise | 3 | 2009 | 547 | 0.460 |
Why?
| Tocolytic Agents | 6 | 2015 | 8 | 0.460 |
Why?
| Randomized Controlled Trials as Topic | 8 | 2021 | 595 | 0.460 |
Why?
| Chorionic Gonadotropin | 1 | 2014 | 19 | 0.460 |
Why?
| Spouse Abuse | 3 | 2012 | 10 | 0.460 |
Why?
| Pregnancy Trimester, First | 1 | 2014 | 23 | 0.450 |
Why?
| Automobile Driving | 1 | 2014 | 27 | 0.450 |
Why?
| Fractures, Bone | 3 | 2014 | 107 | 0.450 |
Why?
| Dinoprostone | 6 | 2002 | 49 | 0.450 |
Why?
| Pregnancy, Prolonged | 5 | 2008 | 6 | 0.440 |
Why?
| Lung Neoplasms | 2 | 2019 | 636 | 0.430 |
Why?
| Multivariate Analysis | 8 | 2015 | 591 | 0.430 |
Why?
| Endometritis | 7 | 2010 | 9 | 0.430 |
Why?
| United States | 20 | 2023 | 5192 | 0.420 |
Why?
| Posture | 2 | 2005 | 66 | 0.420 |
Why?
| Triage | 5 | 2024 | 66 | 0.420 |
Why?
| Truth Disclosure | 1 | 2013 | 16 | 0.420 |
Why?
| Guideline Adherence | 3 | 2013 | 138 | 0.420 |
Why?
| Algorithms | 4 | 2013 | 672 | 0.410 |
Why?
| Case-Control Studies | 14 | 2023 | 1201 | 0.410 |
Why?
| Eclampsia | 7 | 2003 | 7 | 0.400 |
Why?
| Pilot Projects | 5 | 2022 | 721 | 0.400 |
Why?
| Brain Injuries | 1 | 2014 | 159 | 0.400 |
Why?
| Image Interpretation, Computer-Assisted | 1 | 2013 | 107 | 0.390 |
Why?
| Ideal Body Weight | 1 | 2012 | 6 | 0.390 |
Why?
| Body Weights and Measures | 1 | 2012 | 17 | 0.390 |
Why?
| Rupture, Spontaneous | 3 | 2022 | 20 | 0.390 |
Why?
| Blood Transfusion | 5 | 2021 | 127 | 0.380 |
Why?
| Middle Aged | 16 | 2022 | 13028 | 0.370 |
Why?
| Amniocentesis | 11 | 2004 | 15 | 0.370 |
Why?
| Treatment Outcome | 15 | 2024 | 5422 | 0.370 |
Why?
| Diagnosis, Differential | 7 | 2019 | 1046 | 0.370 |
Why?
| Oxytocin | 3 | 2005 | 19 | 0.370 |
Why?
| Gravidity | 3 | 2020 | 5 | 0.370 |
Why?
| Acidosis | 7 | 2004 | 41 | 0.370 |
Why?
| Reference Values | 10 | 2019 | 313 | 0.370 |
Why?
| Contraception | 1 | 2011 | 29 | 0.360 |
Why?
| Intrauterine Devices, Medicated | 1 | 2011 | 1 | 0.360 |
Why?
| Levonorgestrel | 1 | 2011 | 4 | 0.360 |
Why?
| Cohort Studies | 14 | 2021 | 1542 | 0.360 |
Why?
| Puerperal Disorders | 8 | 2015 | 28 | 0.350 |
Why?
| Clinical Competence | 4 | 2022 | 406 | 0.350 |
Why?
| Umbilical Arteries | 12 | 2006 | 23 | 0.350 |
Why?
| Aerospace Medicine | 1 | 2010 | 3 | 0.340 |
Why?
| Fluid Therapy | 2 | 2018 | 78 | 0.340 |
Why?
| Terbutaline | 3 | 2008 | 7 | 0.340 |
Why?
| Quality of Life | 3 | 2023 | 879 | 0.340 |
Why?
| Oxytocics | 4 | 2016 | 7 | 0.320 |
Why?
| Battered Women | 1 | 2009 | 2 | 0.320 |
Why?
| Amnion | 5 | 2020 | 13 | 0.310 |
Why?
| Lung | 6 | 2011 | 509 | 0.310 |
Why?
| Chi-Square Distribution | 9 | 2012 | 288 | 0.310 |
Why?
| Coloring Agents | 4 | 2004 | 69 | 0.300 |
Why?
| Hospitalization | 5 | 2024 | 736 | 0.300 |
Why?
| Birth Injuries | 5 | 2013 | 9 | 0.300 |
Why?
| Bibliometrics | 1 | 2008 | 16 | 0.300 |
Why?
| Anemia, Sickle Cell | 2 | 2021 | 106 | 0.300 |
Why?
| Fibronectins | 3 | 2011 | 37 | 0.300 |
Why?
| Publishing | 1 | 2008 | 37 | 0.290 |
Why?
| Infant, Newborn, Diseases | 3 | 2014 | 56 | 0.290 |
Why?
| Progestins | 3 | 2014 | 11 | 0.290 |
Why?
| Medicaid | 5 | 2023 | 264 | 0.290 |
Why?
| Chorioamnionitis | 4 | 2017 | 14 | 0.290 |
Why?
| Extraembryonic Membranes | 4 | 2001 | 5 | 0.280 |
Why?
| Homocysteine | 1 | 2008 | 126 | 0.280 |
Why?
| ROC Curve | 15 | 2016 | 253 | 0.280 |
Why?
| Hospitals | 2 | 2020 | 182 | 0.260 |
Why?
| Risk Assessment | 9 | 2019 | 1327 | 0.260 |
Why?
| Hydrogen-Ion Concentration | 14 | 2011 | 178 | 0.260 |
Why?
| Hypercalcemia | 1 | 2006 | 34 | 0.260 |
Why?
| Prognosis | 8 | 2018 | 2099 | 0.260 |
Why?
| Logistic Models | 7 | 2011 | 925 | 0.260 |
Why?
| Puerperal Infection | 4 | 2005 | 6 | 0.260 |
Why?
| Remote Consultation | 2 | 2017 | 29 | 0.250 |
Why?
| Renal Insufficiency | 2 | 2006 | 113 | 0.250 |
Why?
| Brachial Plexus | 5 | 2013 | 12 | 0.250 |
Why?
| Maternal Age | 6 | 2015 | 45 | 0.250 |
Why?
| Body Weight | 3 | 2013 | 523 | 0.250 |
Why?
| Version, Fetal | 1 | 2005 | 1 | 0.250 |
Why?
| Platelet Count | 10 | 2001 | 75 | 0.250 |
Why?
| Lifting | 1 | 2005 | 2 | 0.250 |
Why?
| Cerebral Palsy | 3 | 2016 | 38 | 0.240 |
Why?
| Exercise Therapy | 2 | 2023 | 100 | 0.240 |
Why?
| Sex Education | 1 | 2025 | 16 | 0.240 |
Why?
| Puberty | 1 | 2025 | 23 | 0.240 |
Why?
| Smoking | 4 | 2018 | 520 | 0.240 |
Why?
| Placenta, Retained | 3 | 2016 | 4 | 0.240 |
Why?
| Noise | 1 | 2005 | 41 | 0.240 |
Why?
| Male | 17 | 2022 | 26761 | 0.230 |
Why?
| Labetalol | 1 | 2024 | 2 | 0.230 |
Why?
| Chorion | 1 | 2004 | 1 | 0.220 |
Why?
| Noise, Occupational | 1 | 2024 | 3 | 0.220 |
Why?
| Intensive Care, Neonatal | 2 | 2003 | 24 | 0.220 |
Why?
| Health Education | 1 | 2025 | 156 | 0.220 |
Why?
| Patient Care Team | 3 | 2021 | 272 | 0.220 |
Why?
| Depression | 3 | 2017 | 600 | 0.210 |
Why?
| Labor Stage, First | 5 | 2015 | 8 | 0.210 |
Why?
| Home Infusion Therapy | 1 | 2003 | 1 | 0.210 |
Why?
| Weight Gain | 4 | 2013 | 240 | 0.210 |
Why?
| Urinary Tract Infections | 1 | 2023 | 57 | 0.210 |
Why?
| Blood Volume | 2 | 2018 | 66 | 0.200 |
Why?
| Confidence Intervals | 5 | 2016 | 158 | 0.200 |
Why?
| Chorionic Villi | 2 | 2019 | 3 | 0.200 |
Why?
| Aminohippuric Acids | 2 | 2002 | 2 | 0.200 |
Why?
| Caregivers | 1 | 2025 | 240 | 0.200 |
Why?
| Polymorphism, Single Nucleotide | 4 | 2010 | 505 | 0.200 |
Why?
| International Classification of Diseases | 2 | 2015 | 67 | 0.200 |
Why?
| Marital Status | 2 | 2009 | 19 | 0.200 |
Why?
| Abortion, Therapeutic | 1 | 2002 | 3 | 0.200 |
Why?
| Pubic Symphysis | 2 | 2015 | 3 | 0.200 |
Why?
| Exudates and Transudates | 1 | 2002 | 4 | 0.200 |
Why?
| Anticonvulsants | 3 | 2016 | 134 | 0.200 |
Why?
| Hospitals, Military | 2 | 2014 | 6 | 0.200 |
Why?
| Energy Metabolism | 2 | 2013 | 302 | 0.200 |
Why?
| Intrauterine Devices | 2 | 2012 | 4 | 0.200 |
Why?
| Mandatory Reporting | 2 | 2012 | 12 | 0.190 |
Why?
| Sutures | 1 | 2002 | 39 | 0.190 |
Why?
| Hospitals, Teaching | 2 | 2020 | 54 | 0.190 |
Why?
| Embryo Implantation | 1 | 2002 | 5 | 0.190 |
Why?
| Acute Disease | 2 | 2022 | 373 | 0.190 |
Why?
| Hematoma | 1 | 2002 | 65 | 0.190 |
Why?
| Drainage | 1 | 2002 | 87 | 0.190 |
Why?
| Anti-Inflammatory Agents | 2 | 2000 | 166 | 0.180 |
Why?
| Emergency Service, Hospital | 2 | 2024 | 522 | 0.180 |
Why?
| Licensure | 1 | 2021 | 14 | 0.180 |
Why?
| Health Insurance Portability and Accountability Act | 1 | 2021 | 14 | 0.180 |
Why?
| Uterine Contraction | 3 | 2008 | 31 | 0.180 |
Why?
| South Carolina | 3 | 2015 | 23 | 0.180 |
Why?
| Tissue Plasminogen Activator | 1 | 2022 | 109 | 0.180 |
Why?
| Term Birth | 3 | 2015 | 16 | 0.180 |
Why?
| Mothers | 2 | 2017 | 270 | 0.180 |
Why?
| Reproductive Health | 1 | 2021 | 8 | 0.180 |
Why?
| Technology | 1 | 2021 | 23 | 0.180 |
Why?
| Risk Adjustment | 1 | 2021 | 16 | 0.180 |
Why?
| Chronic Disease | 5 | 2024 | 586 | 0.180 |
Why?
| Fatal Outcome | 2 | 2019 | 197 | 0.180 |
Why?
| Infant | 6 | 2023 | 3733 | 0.180 |
Why?
| Hysterectomy | 4 | 2021 | 90 | 0.180 |
Why?
| Antithrombin Proteins | 1 | 2020 | 1 | 0.170 |
Why?
| Placenta Accreta | 1 | 2021 | 26 | 0.170 |
Why?
| Prolapse | 1 | 2020 | 6 | 0.170 |
Why?
| Child | 3 | 2025 | 7248 | 0.170 |
Why?
| Maternal Health Services | 1 | 2021 | 28 | 0.170 |
Why?
| Sleep | 1 | 2002 | 187 | 0.170 |
Why?
| Probability | 6 | 2008 | 172 | 0.170 |
Why?
| Biophysical Phenomena | 3 | 2014 | 18 | 0.170 |
Why?
| Patient Care Planning | 1 | 2020 | 68 | 0.170 |
Why?
| Postoperative Complications | 8 | 2017 | 1068 | 0.170 |
Why?
| Surrogate Mothers | 1 | 2019 | 4 | 0.160 |
Why?
| Quality Improvement | 1 | 2022 | 226 | 0.160 |
Why?
| Chest Pain | 1 | 2019 | 57 | 0.160 |
Why?
| L-Lactate Dehydrogenase | 7 | 2001 | 71 | 0.160 |
Why?
| Cross-Sectional Studies | 4 | 2017 | 1678 | 0.160 |
Why?
| Uterine Cervical Incompetence | 2 | 2011 | 3 | 0.160 |
Why?
| Misoprostol | 3 | 2016 | 5 | 0.160 |
Why?
| Cerclage, Cervical | 2 | 2011 | 8 | 0.160 |
Why?
| Dyspnea | 1 | 2019 | 78 | 0.160 |
Why?
| Abdominal Pain | 1 | 2020 | 85 | 0.160 |
Why?
| Honduras | 1 | 2019 | 2 | 0.160 |
Why?
| Guatemala | 1 | 2019 | 5 | 0.160 |
Why?
| Office Visits | 2 | 2013 | 45 | 0.160 |
Why?
| Acyclovir | 1 | 2019 | 8 | 0.160 |
Why?
| Colombia | 1 | 2019 | 15 | 0.160 |
Why?
| Contraception Behavior | 1 | 2019 | 12 | 0.160 |
Why?
| Mental Health Services | 1 | 2022 | 212 | 0.160 |
Why?
| Lithotripsy, Laser | 1 | 2018 | 6 | 0.160 |
Why?
| Tomography, X-Ray Computed | 3 | 2022 | 1165 | 0.150 |
Why?
| Infant, Premature, Diseases | 3 | 2020 | 94 | 0.150 |
Why?
| Critical Illness | 1 | 2021 | 317 | 0.150 |
Why?
| Internet | 1 | 2021 | 263 | 0.150 |
Why?
| Australia | 3 | 2012 | 89 | 0.150 |
Why?
| Estradiol | 2 | 2002 | 214 | 0.150 |
Why?
| Medical Records | 4 | 2014 | 87 | 0.150 |
Why?
| Obstetric Surgical Procedures | 1 | 2018 | 2 | 0.150 |
Why?
| Cell Adhesion Molecules | 1 | 2019 | 86 | 0.150 |
Why?
| Wounds and Injuries | 3 | 2009 | 309 | 0.150 |
Why?
| Vaginosis, Bacterial | 2 | 2011 | 8 | 0.150 |
Why?
| Linear Models | 7 | 2021 | 287 | 0.150 |
Why?
| Fetal Development | 2 | 2016 | 50 | 0.150 |
Why?
| Seasons | 1 | 1998 | 92 | 0.150 |
Why?
| Early Diagnosis | 1 | 2018 | 95 | 0.140 |
Why?
| Age Factors | 3 | 2011 | 1132 | 0.140 |
Why?
| Glucose Tolerance Test | 2 | 2010 | 60 | 0.140 |
Why?
| Temperature | 2 | 1998 | 183 | 0.140 |
Why?
| Heart Defects, Congenital | 1 | 2023 | 619 | 0.140 |
Why?
| Trial of Labor | 6 | 2008 | 6 | 0.140 |
Why?
| Medical Laboratory Personnel | 1 | 1997 | 5 | 0.140 |
Why?
| Emergency Medical Services | 2 | 2012 | 114 | 0.140 |
Why?
| Severity of Illness Index | 7 | 2010 | 1026 | 0.140 |
Why?
| Pyelonephritis | 1 | 2017 | 5 | 0.140 |
Why?
| Proportional Hazards Models | 2 | 2015 | 443 | 0.140 |
Why?
| Antiviral Agents | 1 | 2019 | 178 | 0.140 |
Why?
| Aged | 3 | 2022 | 10121 | 0.140 |
Why?
| Actinomyces | 1 | 2017 | 12 | 0.140 |
Why?
| Actinomycosis | 1 | 2017 | 10 | 0.140 |
Why?
| Indomethacin | 2 | 2015 | 35 | 0.140 |
Why?
| Cesarean Section, Repeat | 3 | 2003 | 7 | 0.140 |
Why?
| Professional Competence | 1 | 1997 | 42 | 0.140 |
Why?
| Malpractice | 2 | 2008 | 15 | 0.140 |
Why?
| Self-Injurious Behavior | 1 | 2017 | 30 | 0.140 |
Why?
| Fetal Organ Maturity | 5 | 2000 | 8 | 0.130 |
Why?
| Antioxidants | 1 | 2019 | 256 | 0.130 |
Why?
| Health Knowledge, Attitudes, Practice | 2 | 2025 | 509 | 0.130 |
Why?
| Telephone | 2 | 2017 | 71 | 0.130 |
Why?
| Hematocrit | 3 | 2012 | 44 | 0.130 |
Why?
| Kidney | 1 | 2021 | 707 | 0.130 |
Why?
| Reactive Oxygen Species | 1 | 2019 | 421 | 0.130 |
Why?
| Betamethasone | 3 | 2016 | 5 | 0.130 |
Why?
| Symptom Assessment | 1 | 2016 | 32 | 0.130 |
Why?
| Brain Waves | 1 | 2016 | 19 | 0.130 |
Why?
| Patient Care Management | 1 | 2016 | 18 | 0.130 |
Why?
| Systole | 1 | 2016 | 72 | 0.130 |
Why?
| Hospitals, University | 3 | 2014 | 75 | 0.130 |
Why?
| Intestinal Diseases, Parasitic | 1 | 2016 | 3 | 0.130 |
Why?
| Suicidal Ideation | 1 | 2017 | 109 | 0.130 |
Why?
| Colposcopy | 1 | 2016 | 17 | 0.130 |
Why?
| Socioeconomic Factors | 2 | 2016 | 610 | 0.130 |
Why?
| Magnetoencephalography | 1 | 2016 | 86 | 0.130 |
Why?
| Pubic Symphysis Diastasis | 1 | 2015 | 2 | 0.130 |
Why?
| Hospitals, Community | 2 | 2014 | 19 | 0.120 |
Why?
| Humeral Fractures | 2 | 2013 | 8 | 0.120 |
Why?
| Clavicle | 2 | 2013 | 6 | 0.120 |
Why?
| Employment | 1 | 1996 | 93 | 0.120 |
Why?
| Twins, Dizygotic | 1 | 1995 | 7 | 0.120 |
Why?
| Urologic Diseases | 1 | 2015 | 9 | 0.120 |
Why?
| Neuroprotective Agents | 1 | 2016 | 101 | 0.120 |
Why?
| Pregnancy in Diabetics | 4 | 2010 | 27 | 0.120 |
Why?
| Language Development Disorders | 1 | 2015 | 18 | 0.120 |
Why?
| Humidity | 1 | 1995 | 4 | 0.120 |
Why?
| Insulin | 2 | 2007 | 479 | 0.120 |
Why?
| Follow-Up Studies | 7 | 2017 | 2279 | 0.120 |
Why?
| Drug Implants | 2 | 2011 | 35 | 0.120 |
Why?
| Episiotomy | 1 | 2014 | 7 | 0.110 |
Why?
| Progesterone | 1 | 2014 | 58 | 0.110 |
Why?
| Animal Assisted Therapy | 1 | 2014 | 4 | 0.110 |
Why?
| Safety | 1 | 2015 | 79 | 0.110 |
Why?
| Sheep | 1 | 2014 | 96 | 0.110 |
Why?
| Southwestern United States | 1 | 2014 | 17 | 0.110 |
Why?
| Naval Medicine | 2 | 2009 | 5 | 0.110 |
Why?
| Louisiana | 1 | 2014 | 41 | 0.110 |
Why?
| Southeastern United States | 1 | 2014 | 47 | 0.110 |
Why?
| Physician-Patient Relations | 2 | 2013 | 143 | 0.110 |
Why?
| Clinical Protocols | 2 | 2012 | 108 | 0.110 |
Why?
| Stress, Psychological | 3 | 2008 | 273 | 0.110 |
Why?
| Calcium Channel Blockers | 1 | 1994 | 60 | 0.110 |
Why?
| Oxidative Stress | 1 | 2019 | 807 | 0.110 |
Why?
| Academic Medical Centers | 1 | 2014 | 151 | 0.110 |
Why?
| Health Care Costs | 1 | 2015 | 174 | 0.110 |
Why?
| Cost-Benefit Analysis | 1 | 2015 | 267 | 0.110 |
Why?
| Analysis of Variance | 7 | 2001 | 554 | 0.110 |
Why?
| Xylenes | 1 | 1993 | 4 | 0.110 |
Why?
| Insulin-Like Growth Factor II | 2 | 2010 | 18 | 0.110 |
Why?
| Premedication | 1 | 1993 | 18 | 0.110 |
Why?
| Cefazolin | 1 | 1993 | 11 | 0.100 |
Why?
| Healthy People Programs | 1 | 2013 | 4 | 0.100 |
Why?
| Curettage | 1 | 1993 | 13 | 0.100 |
Why?
| Counseling | 1 | 2014 | 136 | 0.100 |
Why?
| Data Collection | 2 | 2012 | 290 | 0.100 |
Why?
| Brain Diseases | 2 | 2005 | 79 | 0.100 |
Why?
| Attention Deficit Disorder with Hyperactivity | 1 | 2015 | 178 | 0.100 |
Why?
| Intraoperative Care | 1 | 1993 | 51 | 0.100 |
Why?
| Image Enhancement | 1 | 2013 | 52 | 0.100 |
Why?
| Placenta Previa | 1 | 1993 | 7 | 0.100 |
Why?
| Depression, Postpartum | 1 | 2013 | 46 | 0.100 |
Why?
| Uterine Cervical Neoplasms | 1 | 2016 | 299 | 0.100 |
Why?
| Anti-Infective Agents, Local | 1 | 1993 | 31 | 0.100 |
Why?
| Adnexa Uteri | 1 | 2012 | 1 | 0.100 |
Why?
| Digestive System | 1 | 2012 | 13 | 0.100 |
Why?
| Retroperitoneal Space | 1 | 2012 | 26 | 0.100 |
Why?
| Abdominal Wall | 1 | 2012 | 13 | 0.100 |
Why?
| Peritoneum | 1 | 2012 | 16 | 0.100 |
Why?
| Abdomen | 4 | 2006 | 75 | 0.100 |
Why?
| Patient Admission | 2 | 2005 | 78 | 0.100 |
Why?
| Government Agencies | 1 | 2012 | 15 | 0.100 |
Why?
| Birth Rate | 1 | 2012 | 3 | 0.100 |
Why?
| Local Government | 1 | 2012 | 23 | 0.100 |
Why?
| Return to Work | 1 | 2012 | 11 | 0.100 |
Why?
| Hemoglobins | 1 | 2013 | 112 | 0.100 |
Why?
| Patient Care | 1 | 2012 | 57 | 0.100 |
Why?
| Reference Standards | 1 | 2012 | 54 | 0.100 |
Why?
| Attitude of Health Personnel | 3 | 2012 | 360 | 0.100 |
Why?
| Motor Activity | 1 | 2013 | 223 | 0.100 |
Why?
| Administration, Oral | 3 | 2024 | 451 | 0.090 |
Why?
| Administration, Intravaginal | 4 | 2014 | 7 | 0.090 |
Why?
| Desogestrel | 1 | 2011 | 2 | 0.090 |
Why?
| Urination | 1 | 2011 | 20 | 0.090 |
Why?
| Contraceptive Agents, Female | 1 | 2011 | 5 | 0.090 |
Why?
| Osmolar Concentration | 1 | 2011 | 62 | 0.090 |
Why?
| Reproductive History | 1 | 2011 | 4 | 0.090 |
Why?
| Emotions | 1 | 2013 | 174 | 0.090 |
Why?
| Drug Eruptions | 1 | 2011 | 14 | 0.090 |
Why?
| Breech Presentation | 2 | 2005 | 2 | 0.090 |
Why?
| Anxiety | 1 | 2014 | 300 | 0.090 |
Why?
| Personal Satisfaction | 1 | 2012 | 75 | 0.090 |
Why?
| Traction | 1 | 2011 | 8 | 0.090 |
Why?
| Guidelines as Topic | 1 | 2012 | 111 | 0.090 |
Why?
| Hypoxia-Ischemia, Brain | 2 | 2010 | 60 | 0.090 |
Why?
| Surgical Sponges | 1 | 2011 | 6 | 0.090 |
Why?
| Labor Stage, Second | 2 | 2008 | 3 | 0.090 |
Why?
| Periodicals as Topic | 2 | 2010 | 61 | 0.090 |
Why?
| Deglutition | 1 | 2011 | 44 | 0.090 |
Why?
| Medical Errors | 1 | 2011 | 23 | 0.090 |
Why?
| Fetal Proteins | 1 | 2011 | 5 | 0.090 |
Why?
| 17-alpha-Hydroxyprogesterone | 1 | 2011 | 1 | 0.090 |
Why?
| Infusions, Intravenous | 2 | 2003 | 220 | 0.090 |
Why?
| Weight-Bearing | 1 | 2011 | 45 | 0.090 |
Why?
| Communication | 1 | 2013 | 257 | 0.090 |
Why?
| Metronidazole | 1 | 2011 | 28 | 0.090 |
Why?
| Genomic Imprinting | 2 | 2007 | 12 | 0.090 |
Why?
| Family Practice | 1 | 2012 | 101 | 0.090 |
Why?
| Receptor, IGF Type 2 | 1 | 2010 | 4 | 0.090 |
Why?
| Hemostasis, Surgical | 2 | 2005 | 12 | 0.090 |
Why?
| RNA, Untranslated | 1 | 2010 | 14 | 0.090 |
Why?
| Hemodynamics | 1 | 2012 | 263 | 0.090 |
Why?
| Appendicitis | 2 | 2009 | 66 | 0.090 |
Why?
| Qualitative Research | 1 | 2013 | 364 | 0.090 |
Why?
| Foreign Bodies | 1 | 2011 | 66 | 0.090 |
Why?
| Hypersensitivity | 1 | 2011 | 81 | 0.090 |
Why?
| Aviation | 1 | 2010 | 5 | 0.090 |
Why?
| Length of Stay | 3 | 2021 | 663 | 0.090 |
Why?
| Longitudinal Studies | 2 | 2011 | 747 | 0.090 |
Why?
| Haplotypes | 2 | 2007 | 92 | 0.090 |
Why?
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2010 | 4 | 0.080 |
Why?
| Monitoring, Physiologic | 1 | 2011 | 122 | 0.080 |
Why?
| Seizures | 2 | 2003 | 208 | 0.080 |
Why?
| Program Evaluation | 2 | 2025 | 353 | 0.080 |
Why?
| Fetal Movement | 2 | 2000 | 18 | 0.080 |
Why?
| Anti-Bacterial Agents | 3 | 2023 | 807 | 0.080 |
Why?
| Heart Diseases | 2 | 2005 | 216 | 0.080 |
Why?
| Pelvis | 2 | 2015 | 69 | 0.080 |
Why?
| Anti-Infective Agents | 1 | 2011 | 107 | 0.080 |
Why?
| Child, Preschool | 2 | 2015 | 4076 | 0.080 |
Why?
| Physical Examination | 3 | 2003 | 99 | 0.080 |
Why?
| Cardiac Complexes, Premature | 1 | 2009 | 3 | 0.080 |
Why?
| Clothing | 1 | 2009 | 5 | 0.080 |
Why?
| Perinatal Care | 2 | 2020 | 28 | 0.080 |
Why?
| Education, Medical, Continuing | 1 | 2010 | 72 | 0.080 |
Why?
| Meconium | 2 | 1999 | 6 | 0.080 |
Why?
| Exercise Tolerance | 1 | 2009 | 46 | 0.080 |
Why?
| Social Perception | 1 | 2009 | 28 | 0.080 |
Why?
| Hemangioendothelioma, Epithelioid | 1 | 2009 | 2 | 0.080 |
Why?
| Suppositories | 3 | 2015 | 3 | 0.080 |
Why?
| Physicians | 2 | 2012 | 241 | 0.080 |
Why?
| Physician's Role | 1 | 2009 | 49 | 0.080 |
Why?
| Research Design | 2 | 2008 | 359 | 0.080 |
Why?
| Medical History Taking | 1 | 2009 | 47 | 0.080 |
Why?
| Patient Preference | 1 | 2009 | 43 | 0.080 |
Why?
| Anthropometry | 2 | 2006 | 101 | 0.080 |
Why?
| Evidence-Based Medicine | 2 | 2009 | 261 | 0.080 |
Why?
| Attitude to Death | 1 | 2008 | 11 | 0.080 |
Why?
| Surgical Procedures, Operative | 1 | 2009 | 64 | 0.080 |
Why?
| Meta-Analysis as Topic | 1 | 2008 | 40 | 0.080 |
Why?
| Emergency Treatment | 2 | 2008 | 28 | 0.070 |
Why?
| Cardiotocography | 2 | 2005 | 6 | 0.070 |
Why?
| Pregnancy, Ectopic | 1 | 2008 | 9 | 0.070 |
Why?
| Forecasting | 2 | 2007 | 154 | 0.070 |
Why?
| Asphyxia Neonatorum | 2 | 2010 | 6 | 0.070 |
Why?
| Creatinine | 2 | 2006 | 150 | 0.070 |
Why?
| Brain | 1 | 2016 | 1323 | 0.070 |
Why?
| Fecal Incontinence | 1 | 2008 | 15 | 0.070 |
Why?
| Societies, Medical | 2 | 2006 | 200 | 0.070 |
Why?
| Constipation | 1 | 2008 | 37 | 0.070 |
Why?
| Spectrophotometry | 2 | 1999 | 32 | 0.070 |
Why?
| p-Aminohippuric Acid | 2 | 1999 | 11 | 0.070 |
Why?
| Administration, Intravenous | 2 | 2020 | 73 | 0.070 |
Why?
| Genetic Diseases, Inborn | 2 | 1999 | 24 | 0.070 |
Why?
| Perinatal Mortality | 2 | 2020 | 3 | 0.070 |
Why?
| Double-Blind Method | 3 | 2020 | 713 | 0.070 |
Why?
| Nurse's Role | 1 | 2007 | 70 | 0.070 |
Why?
| Breast Feeding | 1 | 2009 | 197 | 0.070 |
Why?
| Sepsis | 3 | 2009 | 239 | 0.070 |
Why?
| Glucocorticoids | 2 | 2016 | 235 | 0.070 |
Why?
| Abortion, Induced | 2 | 1998 | 22 | 0.070 |
Why?
| Body Size | 1 | 2007 | 33 | 0.070 |
Why?
| Antacids | 1 | 2006 | 11 | 0.070 |
Why?
| Workload | 1 | 2006 | 46 | 0.070 |
Why?
| Thinness | 1 | 2006 | 44 | 0.060 |
Why?
| Drug Administration Schedule | 4 | 2011 | 374 | 0.060 |
Why?
| Gastroesophageal Reflux | 1 | 2006 | 48 | 0.060 |
Why?
| Ludwig's Angina | 1 | 2006 | 1 | 0.060 |
Why?
| Thrombocytopenia | 4 | 2000 | 89 | 0.060 |
Why?
| Mesothelioma | 1 | 2005 | 15 | 0.060 |
Why?
| Comorbidity | 2 | 2023 | 625 | 0.060 |
Why?
| Leptin | 1 | 2007 | 148 | 0.060 |
Why?
| Uterine Neoplasms | 1 | 2005 | 60 | 0.060 |
Why?
| Blood Gas Monitoring, Transcutaneous | 1 | 2005 | 7 | 0.060 |
Why?
| Acid-Base Imbalance | 1 | 2005 | 1 | 0.060 |
Why?
| Aspartate Aminotransferases | 4 | 2001 | 49 | 0.060 |
Why?
| Gene Frequency | 3 | 2010 | 98 | 0.060 |
Why?
| Liver Neoplasms | 1 | 2009 | 333 | 0.060 |
Why?
| Analgesics | 1 | 2006 | 107 | 0.060 |
Why?
| Colonic Pseudo-Obstruction | 1 | 2004 | 3 | 0.060 |
Why?
| Antibiotic Prophylaxis | 1 | 2005 | 61 | 0.060 |
Why?
| Pain, Postoperative | 1 | 2006 | 169 | 0.060 |
Why?
| Hypoglycemia | 1 | 2005 | 59 | 0.060 |
Why?
| Vagina | 2 | 2011 | 46 | 0.060 |
Why?
| Workplace | 1 | 2005 | 94 | 0.060 |
Why?
| Calcium | 1 | 2006 | 376 | 0.060 |
Why?
| Proteins | 1 | 2007 | 348 | 0.060 |
Why?
| Statistics, Nonparametric | 3 | 2011 | 192 | 0.060 |
Why?
| False Positive Reactions | 3 | 2007 | 63 | 0.060 |
Why?
| Pelvic Inflammatory Disease | 1 | 2004 | 8 | 0.050 |
Why?
| Biophysics | 2 | 2004 | 15 | 0.050 |
Why?
| Thrombophlebitis | 1 | 2004 | 18 | 0.050 |
Why?
| Arterial Pressure | 1 | 2024 | 45 | 0.050 |
Why?
| Palliative Care | 1 | 2006 | 214 | 0.050 |
Why?
| Glycoproteins | 1 | 2004 | 122 | 0.050 |
Why?
| Urogenital System | 1 | 2003 | 4 | 0.050 |
Why?
| Pregnancy Trimesters | 2 | 2017 | 13 | 0.050 |
Why?
| Swimming | 1 | 2003 | 22 | 0.050 |
Why?
| Infusion Pumps | 1 | 2003 | 13 | 0.050 |
Why?
| Platelet Storage Pool Deficiency | 1 | 2003 | 1 | 0.050 |
Why?
| Injections, Subcutaneous | 1 | 2003 | 51 | 0.050 |
Why?
| Recurrence | 2 | 2003 | 672 | 0.050 |
Why?
| Outpatients | 1 | 2004 | 125 | 0.050 |
Why?
| Weights and Measures | 1 | 2002 | 3 | 0.050 |
Why?
| Propionates | 1 | 2003 | 24 | 0.050 |
Why?
| Sphingomyelins | 2 | 2000 | 8 | 0.050 |
Why?
| Phosphatidylcholines | 2 | 2000 | 27 | 0.050 |
Why?
| Multiple Organ Failure | 1 | 2003 | 49 | 0.050 |
Why?
| Hospital Costs | 1 | 2003 | 72 | 0.050 |
Why?
| Pregnancy Tests | 1 | 2002 | 2 | 0.050 |
Why?
| Emergencies | 2 | 2021 | 81 | 0.050 |
Why?
| Autopsy | 1 | 2022 | 48 | 0.050 |
Why?
| Kidney Diseases | 1 | 2005 | 220 | 0.050 |
Why?
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2002 | 4 | 0.050 |
Why?
| Ovarian Diseases | 1 | 2002 | 2 | 0.050 |
Why?
| Blood Pressure Determination | 2 | 2003 | 42 | 0.050 |
Why?
| Gels | 2 | 2002 | 22 | 0.050 |
Why?
| Tissue Expansion | 1 | 2002 | 4 | 0.050 |
Why?
| Health Promotion | 1 | 2005 | 270 | 0.050 |
Why?
| Disseminated Intravascular Coagulation | 2 | 1999 | 6 | 0.050 |
Why?
| Surgical Instruments | 1 | 2002 | 28 | 0.050 |
Why?
| Immunization, Passive | 1 | 2021 | 29 | 0.050 |
Why?
| Contrast Media | 1 | 2003 | 193 | 0.050 |
Why?
| Risk | 3 | 2013 | 316 | 0.050 |
Why?
| Wound Healing | 2 | 1994 | 219 | 0.050 |
Why?
| Proteinuria | 3 | 1999 | 39 | 0.050 |
Why?
| Dose-Response Relationship, Drug | 3 | 2006 | 1378 | 0.050 |
Why?
| Injections, Intramuscular | 3 | 2009 | 56 | 0.040 |
Why?
| Patient Acceptance of Health Care | 1 | 2024 | 358 | 0.040 |
Why?
| Shoulder | 2 | 2008 | 19 | 0.040 |
Why?
| Leukocytosis | 1 | 2000 | 12 | 0.040 |
Why?
| Respiration | 1 | 2000 | 101 | 0.040 |
Why?
| Models, Theoretical | 2 | 1999 | 185 | 0.040 |
Why?
| Sodium Chloride | 2 | 1998 | 56 | 0.040 |
Why?
| Ambulatory Care | 1 | 2002 | 239 | 0.040 |
Why?
| Intensive Care Units | 1 | 2021 | 243 | 0.040 |
Why?
| Reoperation | 1 | 2002 | 465 | 0.040 |
Why?
| Blood Gas Analysis | 2 | 2003 | 29 | 0.040 |
Why?
| Disorders of Sex Development | 1 | 1999 | 7 | 0.040 |
Why?
| Embryo Transfer | 1 | 2019 | 24 | 0.040 |
Why?
| Erythrocyte Count | 1 | 1999 | 4 | 0.040 |
Why?
| Fetal Hemoglobin | 1 | 1999 | 5 | 0.040 |
Why?
| Fetomaternal Transfusion | 1 | 1999 | 3 | 0.040 |
Why?
| Mental Health | 1 | 2022 | 240 | 0.040 |
Why?
| Animals | 1 | 2014 | 13505 | 0.040 |
Why?
| Lung Diseases | 1 | 2000 | 88 | 0.040 |
Why?
| Placentation | 1 | 2019 | 13 | 0.040 |
Why?
| Recombinant Proteins | 1 | 2020 | 483 | 0.040 |
Why?
| Trophoblasts | 1 | 2019 | 31 | 0.040 |
Why?
| Palpation | 1 | 1998 | 7 | 0.040 |
Why?
| Genotype | 2 | 2010 | 566 | 0.040 |
Why?
| Weather | 1 | 1998 | 6 | 0.040 |
Why?
| Labor Presentation | 1 | 1998 | 1 | 0.040 |
Why?
| Obstetrical Forceps | 2 | 2015 | 6 | 0.040 |
Why?
| Dilatation and Curettage | 2 | 1998 | 2 | 0.040 |
Why?
| Alanine Transaminase | 2 | 1999 | 122 | 0.040 |
Why?
| Education, Medical, Graduate | 1 | 2020 | 219 | 0.040 |
Why?
| Gaucher Disease | 1 | 1998 | 17 | 0.040 |
Why?
| Costs and Cost Analysis | 1 | 1998 | 95 | 0.040 |
Why?
| Databases, Factual | 2 | 2015 | 706 | 0.040 |
Why?
| Skull | 2 | 1995 | 80 | 0.040 |
Why?
| Carboprost | 1 | 1998 | 1 | 0.040 |
Why?
| Abortifacient Agents, Nonsteroidal | 1 | 1998 | 2 | 0.040 |
Why?
| Cerebral Hemorrhage | 2 | 2014 | 97 | 0.040 |
Why?
| Critical Care | 1 | 2000 | 222 | 0.040 |
Why?
| Patient Discharge | 1 | 2000 | 330 | 0.040 |
Why?
| Treatment Failure | 2 | 2009 | 122 | 0.040 |
Why?
| Georgia | 1 | 2017 | 42 | 0.030 |
Why?
| Evaluation Studies as Topic | 2 | 1998 | 105 | 0.030 |
Why?
| APACHE | 1 | 2017 | 25 | 0.030 |
Why?
| Nicotine | 1 | 2018 | 180 | 0.030 |
Why?
| Embryonic and Fetal Development | 1 | 1997 | 23 | 0.030 |
Why?
| Indicator Dilution Techniques | 2 | 1997 | 13 | 0.030 |
Why?
| Self Care | 1 | 1998 | 138 | 0.030 |
Why?
| Isotonic Solutions | 1 | 1996 | 20 | 0.030 |
Why?
| Water-Electrolyte Imbalance | 1 | 1996 | 16 | 0.030 |
Why?
| Chlorides | 1 | 1996 | 46 | 0.030 |
Why?
| Suture Techniques | 2 | 1994 | 60 | 0.030 |
Why?
| Therapeutic Irrigation | 2 | 1993 | 29 | 0.030 |
Why?
| Flow Cytometry | 1 | 1999 | 478 | 0.030 |
Why?
| Transportation | 1 | 2016 | 30 | 0.030 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2018 | 197 | 0.030 |
Why?
| Psychiatric Status Rating Scales | 1 | 2017 | 323 | 0.030 |
Why?
| Psychometrics | 1 | 2017 | 230 | 0.030 |
Why?
| Dinoprost | 1 | 1995 | 7 | 0.030 |
Why?
| Cephalopelvic Disproportion | 1 | 2015 | 2 | 0.030 |
Why?
| Rupture | 1 | 2015 | 24 | 0.030 |
Why?
| Depressive Disorder, Major | 1 | 2017 | 148 | 0.030 |
Why?
| Florida | 1 | 1995 | 67 | 0.030 |
Why?
| Occupations | 1 | 1995 | 18 | 0.030 |
Why?
| Fracture Fixation | 1 | 2015 | 18 | 0.030 |
Why?
| Urogenital Abnormalities | 1 | 2015 | 17 | 0.030 |
Why?
| Teratoma | 1 | 1995 | 24 | 0.030 |
Why?
| Administration, Rectal | 1 | 2015 | 8 | 0.030 |
Why?
| Sexual Behavior | 1 | 2016 | 128 | 0.030 |
Why?
| Hematologic Tests | 1 | 1995 | 10 | 0.030 |
Why?
| Smoking Cessation | 1 | 2018 | 315 | 0.030 |
Why?
| Liver Function Tests | 1 | 1995 | 48 | 0.030 |
Why?
| Antibodies, Monoclonal | 1 | 1999 | 481 | 0.030 |
Why?
| Discriminant Analysis | 1 | 1994 | 27 | 0.030 |
Why?
| Cervical Length Measurement | 1 | 2014 | 1 | 0.030 |
Why?
| Radiography | 1 | 2015 | 470 | 0.030 |
Why?
| Interleukin-8 | 1 | 1994 | 86 | 0.030 |
Why?
| Stress, Physiological | 1 | 1995 | 183 | 0.030 |
Why?
| Enterocolitis, Necrotizing | 1 | 2014 | 38 | 0.030 |
Why?
| Drug Administration Routes | 1 | 2013 | 10 | 0.030 |
Why?
| Povidone-Iodine | 1 | 1993 | 8 | 0.030 |
Why?
| Biometry | 3 | 2000 | 21 | 0.030 |
Why?
| Bronchopulmonary Dysplasia | 1 | 2014 | 81 | 0.030 |
Why?
| Interleukin-6 | 1 | 1994 | 278 | 0.030 |
Why?
| Maternal Welfare | 2 | 2004 | 10 | 0.020 |
Why?
| Leukocyte Count | 2 | 2004 | 73 | 0.020 |
Why?
| New Zealand | 1 | 2012 | 20 | 0.020 |
Why?
| Ascites | 1 | 1992 | 32 | 0.020 |
Why?
| Auscultation | 1 | 2012 | 9 | 0.020 |
Why?
| Health Care Surveys | 1 | 2012 | 177 | 0.020 |
Why?
| Injections, Intravenous | 2 | 2003 | 138 | 0.020 |
Why?
| Canada | 1 | 2012 | 104 | 0.020 |
Why?
| Self Report | 1 | 2013 | 210 | 0.020 |
Why?
| Patient Safety | 1 | 2012 | 104 | 0.020 |
Why?
| Disease Progression | 1 | 1995 | 871 | 0.020 |
Why?
| Brain Neoplasms | 1 | 1995 | 291 | 0.020 |
Why?
| Oximetry | 1 | 2012 | 66 | 0.020 |
Why?
| Area Under Curve | 1 | 2011 | 180 | 0.020 |
Why?
| Models, Biological | 1 | 1994 | 735 | 0.020 |
Why?
| Models, Statistical | 1 | 2012 | 230 | 0.020 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 235 | 0.020 |
Why?
| Chromogranins | 1 | 2010 | 6 | 0.020 |
Why?
| Health Planning Guidelines | 1 | 2010 | 12 | 0.020 |
Why?
| Inheritance Patterns | 1 | 2010 | 22 | 0.020 |
Why?
| Uric Acid | 2 | 1999 | 25 | 0.020 |
Why?
| Medical Informatics | 1 | 2010 | 57 | 0.020 |
Why?
| Nausea | 2 | 1999 | 46 | 0.020 |
Why?
| Data Interpretation, Statistical | 1 | 2010 | 164 | 0.020 |
Why?
| Systemic Inflammatory Response Syndrome | 1 | 2009 | 67 | 0.020 |
Why?
| Appendectomy | 1 | 2009 | 36 | 0.020 |
Why?
| Vomiting | 2 | 1999 | 73 | 0.020 |
Why?
| Western Australia | 1 | 2008 | 6 | 0.020 |
Why?
| Biopsy, Fine-Needle | 1 | 2009 | 107 | 0.020 |
Why?
| Virginia | 1 | 2008 | 19 | 0.020 |
Why?
| Flatulence | 1 | 2008 | 3 | 0.020 |
Why?
| Observer Variation | 1 | 2008 | 134 | 0.020 |
Why?
| Rectum | 1 | 2008 | 55 | 0.020 |
Why?
| Linkage Disequilibrium | 1 | 2007 | 39 | 0.020 |
Why?
| Shoulder Fractures | 1 | 2007 | 7 | 0.020 |
Why?
| Pelvic Floor | 1 | 2008 | 52 | 0.020 |
Why?
| Pedigree | 1 | 2007 | 125 | 0.020 |
Why?
| Fathers | 1 | 2007 | 26 | 0.020 |
Why?
| Wisconsin | 1 | 2007 | 42 | 0.020 |
Why?
| Femur | 2 | 2000 | 135 | 0.020 |
Why?
| Obstetrics and Gynecology Department, Hospital | 1 | 2006 | 5 | 0.020 |
Why?
| Adaptation, Psychological | 1 | 2008 | 230 | 0.020 |
Why?
| Liver | 2 | 2009 | 1156 | 0.020 |
Why?
| Heart Failure | 1 | 1992 | 565 | 0.020 |
Why?
| Cytodiagnosis | 1 | 2005 | 43 | 0.020 |
Why?
| Insurance, Liability | 1 | 2005 | 1 | 0.020 |
Why?
| Compensation and Redress | 1 | 2005 | 2 | 0.020 |
Why?
| Liability, Legal | 1 | 2005 | 11 | 0.020 |
Why?
| Diagnosis-Related Groups | 1 | 2005 | 18 | 0.020 |
Why?
| Mental Status Schedule | 1 | 2005 | 15 | 0.020 |
Why?
| Sex Characteristics | 1 | 2007 | 198 | 0.010 |
Why?
| Registries | 1 | 2008 | 581 | 0.010 |
Why?
| Diastole | 1 | 2005 | 70 | 0.010 |
Why?
| Washington | 1 | 2005 | 45 | 0.010 |
Why?
| Blood Flow Velocity | 1 | 2005 | 95 | 0.010 |
Why?
| Pain Measurement | 1 | 2006 | 256 | 0.010 |
Why?
| Cecostomy | 1 | 2004 | 4 | 0.010 |
Why?
| Phenotype | 1 | 2007 | 789 | 0.010 |
Why?
| Delivery Rooms | 1 | 2004 | 1 | 0.010 |
Why?
| Overweight | 1 | 2006 | 224 | 0.010 |
Why?
| Wound Infection | 1 | 2004 | 32 | 0.010 |
Why?
| Decision Making | 1 | 2006 | 282 | 0.010 |
Why?
| Suicide | 1 | 2005 | 85 | 0.010 |
Why?
| Gram-Positive Bacterial Infections | 1 | 2004 | 30 | 0.010 |
Why?
| Injury Severity Score | 1 | 2004 | 167 | 0.010 |
Why?
| Fetal Hypoxia | 1 | 2003 | 2 | 0.010 |
Why?
| Resuscitation | 1 | 2003 | 71 | 0.010 |
Why?
| Vancomycin | 1 | 2004 | 85 | 0.010 |
Why?
| Heparin | 1 | 2004 | 88 | 0.010 |
Why?
| Polyunsaturated Alkamides | 1 | 2003 | 3 | 0.010 |
Why?
| Fever | 1 | 2004 | 112 | 0.010 |
Why?
| Fibrinolytic Agents | 1 | 2004 | 128 | 0.010 |
Why?
| Neutrophils | 1 | 2004 | 147 | 0.010 |
Why?
| Organ Size | 1 | 2003 | 228 | 0.010 |
Why?
| Hypothyroidism | 1 | 2003 | 57 | 0.010 |
Why?
| Tachycardia, Paroxysmal | 1 | 2002 | 6 | 0.010 |
Why?
| Uterine Cervical Diseases | 1 | 2002 | 3 | 0.010 |
Why?
| Laparotomy | 1 | 2002 | 37 | 0.010 |
Why?
| Ovariectomy | 1 | 2002 | 113 | 0.010 |
Why?
| Placebos | 1 | 2002 | 85 | 0.010 |
Why?
| Heart Rate | 1 | 2003 | 318 | 0.010 |
Why?
| Diuresis | 1 | 2001 | 14 | 0.010 |
Why?
| Survival Analysis | 1 | 2002 | 673 | 0.010 |
Why?
| Analgesics, Opioid | 1 | 2006 | 590 | 0.010 |
Why?
| Karyotyping | 1 | 1999 | 78 | 0.010 |
Why?
| Headache | 1 | 1999 | 76 | 0.010 |
Why?
| Liver Diseases | 1 | 1999 | 83 | 0.010 |
Why?
| Asthma | 1 | 2003 | 316 | 0.010 |
Why?
| Pulse | 1 | 1998 | 13 | 0.010 |
Why?
| Stomach | 1 | 1999 | 82 | 0.010 |
Why?
| Mathematics | 1 | 1998 | 40 | 0.010 |
Why?
| Injections | 1 | 1998 | 61 | 0.010 |
Why?
| Heart Arrest | 1 | 1999 | 158 | 0.010 |
Why?
| Blood | 1 | 1997 | 26 | 0.010 |
Why?
| Acidosis, Respiratory | 1 | 1997 | 2 | 0.010 |
Why?
| Blood Specimen Collection | 1 | 1997 | 35 | 0.010 |
Why?
| Pain | 1 | 1999 | 362 | 0.010 |
Why?
| Twin Studies as Topic | 1 | 1996 | 3 | 0.010 |
Why?
| Inflammation | 1 | 2000 | 641 | 0.010 |
Why?
| Diagnostic Tests, Routine | 1 | 1995 | 31 | 0.010 |
Why?
| Feasibility Studies | 1 | 1997 | 406 | 0.010 |
Why?
| Extraction, Obstetrical | 1 | 1992 | 4 | 0.010 |
Why?
| Nerve Compression Syndromes | 1 | 1992 | 6 | 0.010 |
Why?
| Granulation Tissue | 1 | 1992 | 10 | 0.010 |
Why?
| Debridement | 1 | 1992 | 48 | 0.010 |
Why?
| Anemia, Hemolytic | 1 | 1992 | 11 | 0.010 |
Why?
| Random Allocation | 1 | 1992 | 285 | 0.010 |
Why?
| Syndrome | 1 | 1992 | 247 | 0.010 |
Why?
| Diabetes Mellitus | 1 | 1994 | 316 | 0.010 |
Why?
|
|
Magann's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|